You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CE

Pharmacist Perspectives on Multiple Myeloma Management

  • Authors: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC; Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; Jared E. Matya, PharmD, BCOP
  • CE Released: 5/25/2023
  • Valid for credit through: 5/25/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for oncology pharmacists.

The goal of this activity is for learners to be better able to evaluate multiple myeloma (MM) therapies, mitigate drug-drug interactions and treatment side effects, and counsel patients as part of the interprofessional care team.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Pharmacologic management of MM 
  • Have greater competence related to
    • Managing adverse events associated with MM therapies
  • Demonstrate greater confidence in their ability to
    • Educate patients with MM about their treatment


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC

    Assistant Professor of Pharmacy
    Mayo Clinic College of Medicine
    Director of Pharmacy
    Minnesota Oncology
    St. Paul, Minnesota

    Disclosures

    Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, has the following relevant financial relationships:
    Speaker or member of speakers bureau for: GlaxoSmithKline; Janssen; Sanofi

  • Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

    Clinical Pharmacy Manager
    Division of Hematologic Malignancies and Cellular Therapies
    Oncology Pharmacy Residency Program Director
    The University of Kansas Cancer Center
    Westwood, Kansas

    Disclosures

    Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Bristol Myers Squibb Company; Genentech; Incyte Corporation; Kite Pharma, Inc.; Omeros Corporation; Sanofi
    Speaker or member of speakers bureau for: Omeros Corporation

  • Jared E. Matya, PharmD, BCOP

    Adjunct Clinical Assistant Professor
    Clinical Pharmacist Practitioner
    Transplant and Cellular Therapy
    University of Nebraska Medical Center
    Omaha, Nebraska

    Disclosures

    Jared E. Matya, PharmD, BCOP, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Genmab

Editor

  • Megan Whitney, DMD

    Medical Education Director, Medscape, LLC

    Disclosures

    Megan Whitney, DMD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-23-183-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CE

Pharmacist Perspectives on Multiple Myeloma Management

Authors: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC; Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; Jared E. Matya, PharmD, BCOPFaculty and Disclosures

CE Released: 5/25/2023

Valid for credit through: 5/25/2024, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print